These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9580850)

  • 1. Thyroid stunning.
    Coakley AJ
    Eur J Nucl Med; 1998 Mar; 25(3):203-4. PubMed ID: 9580850
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid stunning.
    Medvedec M
    J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid stunning after (131)I diagnostic whole-body scanning.
    McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
    J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
    [No Abstract]   [Full Text] [Related]  

  • 4. Stunning after tracer dosimetry.
    Diehl M; Grünwald F
    J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out].
    Koch W; Knesewitsch P; Tatsch K; Hahn K
    Nuklearmedizin; 2003 Feb; 42(1):10-4. PubMed ID: 12601448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-thyroglobulin antibodies and risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.
    Rosario PW
    J Endocrinol Invest; 2017 Sep; 40(9):1023. PubMed ID: 28569364
    [No Abstract]   [Full Text] [Related]  

  • 9. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioiodine and thyroid cancer: some questions, controversies, and considerations.
    Daniels GH
    Endocr Pract; 2001; 7(4):320-3. PubMed ID: 11497485
    [No Abstract]   [Full Text] [Related]  

  • 11. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Zanin D; van der Schoot JB
    Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine and thyroid cancer.
    Jana S; Abdel-Dayem HM; Young I
    Eur J Nucl Med; 1999 Dec; 26(12):1528-32. PubMed ID: 10638402
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine in treatment of metastatic thyroid cancer.
    Dewan SS; Sharma SM; Ganatra RD
    Int J Nucl Med Biol; 1979; 6(4):213-4. PubMed ID: 528148
    [No Abstract]   [Full Text] [Related]  

  • 14. 123I imaging in the follow-up of differentiated thyroid cancer.
    Fenwick JD; Mallick UK; Perros P
    Clin Oncol (R Coll Radiol); 2001; 13(4):314. PubMed ID: 11554639
    [No Abstract]   [Full Text] [Related]  

  • 15. Whole-body thyroid tumor 123I scintigraphy.
    Gerard SK
    J Nucl Med; 2003 May; 44(5):852. PubMed ID: 12732689
    [No Abstract]   [Full Text] [Related]  

  • 16. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 17. Contamination of a bracelet following iodine-131 therapy: a case report.
    Bybel B; Beebe W; Kim BY; Faiman C
    J Nucl Med Technol; 2000 Dec; 28(4):257-8. PubMed ID: 11142327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The autonomous thyroid nodule: results of treatment with radioiodine].
    Schachter D; Atria A; Pineda G
    Rev Med Chil; 1986 Mar; 114(3):228-31. PubMed ID: 3544122
    [No Abstract]   [Full Text] [Related]  

  • 19. 123Imaging in the follow-up of differentiated thyroid cancer.
    Violet J; Nutting C; Plowman PN; Britton KE
    Clin Oncol (R Coll Radiol); 2001; 13(4):313-4. PubMed ID: 11554638
    [No Abstract]   [Full Text] [Related]  

  • 20. The nonimpact of thyroid stunning: remnant ablation rates in 131I-scanned and nonscanned individuals.
    Morris LF; Waxman AD; Braunstein GD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3507-11. PubMed ID: 11502771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.